Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma, Advanced Interventions: Drug: Oncolytic Adenovirus H101; Drug: Programmed death receptor-1 inhibitor Sponsor: Tianjin Medical University Second Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials